Alaunos Therapeutics (TCRT) Q3 2024 Earnings
TCRT·Reported November 14, 2024·Before market open
Diluted EPS came in at $-0.70, beat the $-4.50 consensus by $3.80.
Diluted EPS
$-0.70beat by $3.80
Consensus: $-4.50
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Alaunos Therapeutics's Q3 2024 earnings report.
Alaunos Therapeutics (TCRT) reported Q3 2024 earnings on November 14, 2024 before market open.
Alaunos Therapeutics reported diluted EPS of $-0.70 for Q3 2024.
EPS beat the consensus estimate of $-4.50 by $3.80.
You can read the 10-Q periodic report (0000950170-24-126793) directly on SEC EDGAR. The filing index links above go to sec.gov.